Total Triiodothyronine (T3)
Females, Age 20-29
The median total T3 for females aged 20-29 in the US population is 116.7 ng/dL, with 90% of this group falling between 90.7 and 170.5 ng/dL.
NHANES 2009-2012 Thyroid Profile (Subsample A) 2009-2012 · Sample size: 280 participants · Unit: ng/dL
Percentile Distribution
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (ng/dL) | 90.7 | 96.2 | 106 | 116.7 | 134 | 154.6 | 170.5 |
| 95% CI | 86.5 | 90 | 101.1 | 113 | 128 | 147.5 | 156.3 |
| Percentile | Value (ng/dL) | 95% CI |
|---|---|---|
| P5 | 90.7 | 86.5 |
| P10 | 96.2 | 90 |
| P25 | 106 | 101.1 |
| P50 | 116.7 | 113 |
| P75 | 134 | 128 |
| P90 | 154.6 | 147.5 |
| P95 | 170.5 | 156.3 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
106 116.7 134
P25 P50 P75
P5 90.7 P95 170.5
Data and Methodology
- Dataset
- NHANES 2009-2012 Thyroid Profile (Subsample A) ( NHANES 2009-2012 Thyroid 2009 , Survey-weighted percentiles from NHANES 2009-2012 Thyroid Profile Subsample A)
- Survey years
- 2009-2012
- Measurement
- Measured by competitive binding immunoenzymatic assay on Beckman Coulter Access. How it was measured
- Sample size
- 280 participants
- Reference population
- US females aged 20-29, excluding pregnant participants, those with self-reported thyroid disease, and current thyroid medication users
- Exclusion criteria
-
- Age under 20
- Pregnant at time of exam (RIDEXPRG == 1)
- Self-reported thyroid disease (MCQ160M == 1)
- Current thyroid medication use (RXDDRUG match against thyroid_drug_list.txt)
- Missing analyte value
- Missing or zero subsample weight (WTSA2YR)
- Notes
- Percentiles computed using the Subsample A two-year weight (WTSA2YR), divided by 2 to pool the 2009-2010 and 2011-2012 cycles.